FDA panel backs Pfizer's low-dose COVID-19 vaccine for kids
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
Stay updated with breaking news from Pfizer S. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
May 28, 2021 The Pfizer/BioNTech vaccine has become the first COVID jab in the European Union to be approved for use in children aged 12-15. — Courtesy photo BRUSSELS — The Pfizer/BioNTech vaccine has become the first coronavirus jab in the European Union to be approved for use in children aged 12-15. Before now, inoculations against COVID-19 had only been available to those aged 16 and above. "The EMA’s human medicines committee (CHMP) has today approved the use of the vaccine from Pfizer/BioNTech called Comirnaty for adolescents from 12 to 15 years old," said Marco...
The US Food and Drug Administration has authorised two changes to Moderna's COVID-19 vaccine that can provide extra doses from each vial. The agency said late Thursday it approved new vials from Moderna that can contain up to 15 doses each, compared with the original vials designed to hold 10 doses. Additionally, regulators said providers can safely extract up to 11 doses from the original 10-dose vials. Those changes will be added to instructions for health care workers. The dosing updates should help bolster US supplies and speed vaccinations as the US nears 100 million inoculations agai...
SEOUL. KAZINFORM South Korea's drug safety agency on Friday approved the vaccine for the novel coronavirus developed by U.S. pharmaceutical company Pfizer Inc. as the country is pushing for the COVID-19 inoculation campaign.
Read more about WHO clears Pfizer-BioNTech coronavirus vaccine for emergency use on Business Standard. The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use